C21 Investments Inc. (CWLXF): Capital Expenditures

Annual figures by period end, from SEC filings.

$244.8K
Year ended 2026-03-31
$2.56M2021-01-31: $227.8K2022-01-31: $2.56M2023-01-31: $442.3K2024-01-31: $521.6K2025-03-31: $406.7K2026-03-31: $244.8K$244.8K
2021-01-31 Capital Expenditures (USD) 2026-03-31
Period endedCapital ExpendituresChange YoYSource filing
2026-03-31$244.8K-39.8%2026-06-12, From 2025-04-01
2025-03-31$406.7Kn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31$521.6K+17.9%2025-06-23, From 2023-02-01
2023-01-31$442.3K-82.7%2024-08-08, From 2022-02-01
2022-01-31$2.56Mn/m2023-07-28, From 2021-02-01
2021-01-31$227.8Kn/a2023-07-28, From 2020-02-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$244.8K-39.8%
Leef Brands Inc. (LEEEF)2025-12-31$642.0K-89.2%
Charlie's Holdings, Inc. (CHUC)2025-12-31$23.0Kn/a
Bon Natural Life Ltd (BON)2025-09-30$6.8K-3.1%
Fitlife Brands, Inc. (FTLF)2025-12-31$42.0K+320.0%
Mannatech Inc (MTEX)2025-12-31$1.35M+355.6%
Natural Alternatives International Inc (NAII)2026-06-30$3.70M+2.4%
Cronos Group Inc. (CRON)2025-12-31$25.72M+107.2%
Marimed Inc. (MRMD)2025-12-31$1.17M-90.2%

Compare CWLXF, LEEEF, CHUC, BON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗